These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36088736)
21. Design and operation of a continuous integrated monoclonal antibody production process. Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347 [TBL] [Abstract][Full Text] [Related]
22. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment. Ding C; Ardeshna H; Gillespie C; Ierapetritou M Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341 [TBL] [Abstract][Full Text] [Related]
23. Semi-continuous biomanufacturing for maximizing the production of complex chemicals and fuels: a case study of amorpha-4,11-diene. Castillo-Saldarriaga C; Sarria S; Santos CNS; Ajikumar PK; Takors R Trends Biotechnol; 2024 Sep; ():. PubMed ID: 39277494 [TBL] [Abstract][Full Text] [Related]
24. Reviewing the process intensification landscape through the introduction of a novel, multitiered classification for downstream processing. Crowley L; Cashen P; Noverraz M; Lobedann M; Nestola P Biotechnol Bioeng; 2024 Mar; 121(3):877-893. PubMed ID: 38214109 [TBL] [Abstract][Full Text] [Related]
25. Halomonas as a chassis. Ye JW; Chen GQ Essays Biochem; 2021 Jul; 65(2):393-403. PubMed ID: 33885142 [TBL] [Abstract][Full Text] [Related]
26. Bioreactors and in situ product recovery techniques for acetone-butanol-ethanol fermentation. Li SY; Chiang CJ; Tseng IT; He CR; Chao YP FEMS Microbiol Lett; 2016 Jul; 363(13):. PubMed ID: 27190167 [TBL] [Abstract][Full Text] [Related]
27. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies. Xenopoulos A J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171 [TBL] [Abstract][Full Text] [Related]
28. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges. Somasundaram B; Pleitt K; Shave E; Baker K; Lua LHL Biotechnol Bioeng; 2018 Dec; 115(12):2893-2907. PubMed ID: 30080940 [TBL] [Abstract][Full Text] [Related]
29. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium. Konstantinov KB; Cooney CL J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595 [TBL] [Abstract][Full Text] [Related]
30. Dynamic model-based evaluation of process configurations for integrated operation of hydrolysis and co-fermentation for bioethanol production from lignocellulose. Morales-Rodriguez R; Meyer AS; Gernaey KV; Sin G Bioresour Technol; 2011 Jan; 102(2):1174-84. PubMed ID: 20961753 [TBL] [Abstract][Full Text] [Related]
31. Effective multiple stages continuous acetone-butanol-ethanol fermentation by immobilized bioreactors: Making full use of fresh corn stalk. Chang Z; Cai D; Wang Y; Chen C; Fu C; Wang G; Qin P; Wang Z; Tan T Bioresour Technol; 2016 Apr; 205():82-9. PubMed ID: 26812141 [TBL] [Abstract][Full Text] [Related]
32. Production of probiotic biomass (Lactobacillus casei) in goat milk whey: comparison of batch, continuous and fed-batch cultures. Aguirre-Ezkauriatza EJ; Aguilar-Yáñez JM; Ramírez-Medrano A; Alvarez MM Bioresour Technol; 2010 Apr; 101(8):2837-44. PubMed ID: 20042330 [TBL] [Abstract][Full Text] [Related]
35. [New opportunities and challenges for hybrid data and model driven bioprocess optimization and scale-up]. Wang G; Tian X; Xia J; Chu J; Zhang S; Zhuang Y Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):1004-1016. PubMed ID: 33783164 [TBL] [Abstract][Full Text] [Related]
36. Biomanufacturing of value-added products from oils or fats: A case study on cellular and fermentation engineering of Yarrowia lipolytica. Liu N; Soong YV; Mirzaee I; Olsen A; Yu P; Wong HW; Xie D Biotechnol Bioeng; 2021 Apr; 118(4):1677-1692. PubMed ID: 33470430 [TBL] [Abstract][Full Text] [Related]
37. Role of ultrasound in assisted fermentation technologies for process enhancements. Pawar SV; Rathod VK Prep Biochem Biotechnol; 2020; 50(6):627-634. PubMed ID: 32065573 [TBL] [Abstract][Full Text] [Related]
38. End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies. Mahal H; Branton H; Farid SS Biotechnol Bioeng; 2021 Sep; 118(9):3468-3485. PubMed ID: 33792918 [TBL] [Abstract][Full Text] [Related]
39. Integrated two-liquid phase bioconversion and product-recovery processes for the oxidation of alkanes: process design and economic evaluation. Mathys RG; Schmid A; Witholt B Biotechnol Bioeng; 1999 Aug; 64(4):459-77. PubMed ID: 10397885 [TBL] [Abstract][Full Text] [Related]
40. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing. Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]